Concepedia

Author

P O Livingston

Memorial Sloan Kettering Cancer Center

Also Known As

P O Livingston, P. O. LIVINGSTON, P. O. Livingston, PhilipO. Livingston

21

Publications

890

Citations

11

H-Index

41

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center
PO

About

P O Livingston is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, immunology, and immunotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

9

9

836

2

Cell Biology

5

5

488

3

Allergy

3

3

327

4

Social Sciences

1

1

36

5

Biomolecular Engineering

1

1

179

P O Livingston

×

11

Publications

871

Citations

11

H-Index

YearCitations

Vaccines containing purified GM2 ganglioside elicit GM2 antibodies in melanoma patients.

P O Livingston, Edward J. Natoli, M J Calves,

Proceedings of the National Academy of Sciences

1987

222

GD3 vaccines for melanoma: superior immunogenicity of keyhole limpet hemocyanin conjugate vaccines.

Friedhelm Helling, A Shang, M J Calves,

PubMed

1994

179

Cell-surface antigens of melanoma recognized by human monoclonal antibodies.

Hiroshi Yamaguchi, K. Furukawa, Sheila R. Fortunato,

Proceedings of the National Academy of Sciences

1987

105

Antibodies against GD2 ganglioside can eradicate syngeneic cancer micrometastases.

Hongjie Zhang, Shengle Zhang, N K Cheung,

PubMed

1998

101

Approaches to augmenting the immunogenicity of the ganglioside GM2 in mice: purified GM2 is superior to whole cells.

P O Livingston, M J Calves, Edward J. Natoli

The Journal of Immunology

1987

67

Antibody response after immunization with the gangliosides GM1, GM2, GM3, GD2 and GD3 in the mouse

P O Livingston, Gerd Ritter, MicheleJones Calves

Cancer Immunology Immunotherapy

1989

53

Serological response patterns of melanoma patients immunized with a GM2 ganglioside conjugate vaccine.

K Kitamura, P O Livingston, Sheila R. Fortunato,

Proceedings of the National Academy of Sciences

1995

52

Ectopic dendrites occur only on cortical pyramidal cells containing elevated GM2 ganglioside in alpha-mannosidosis.

L. A. Goodman, P O Livingston, Steven U. Walkley

Proceedings of the National Academy of Sciences

1991

36

Comparison of approaches for augmenting the serologic response to the individually specific methylcholanthrene-induced sarcoma-Meth A: pretreatment with cyclophosphamide is most effective.

P O Livingston, Albert B. DeLeo, Michael Owen Jones,

The Journal of Immunology

1983

21

Targeted therapy for prostate cancer: the Memorial Sloan-Kettering Cancer Center approach.

Susan F. Slovin, P O Livingston, Neal Rosen,

PubMed

1996

19

Page 1